Disease Landscape and Forecast Insights
Comprehensive market intelligence and actionable insights help you optimize your long-term disease strategy
Report
July 25, 2022
Acute Lymphoblastic Leukemia – Current Treatment – Acute Lymphoblastic Leukemia | Current Treatment: Physician Insights | US
Acute lymphoblastic leukemia (ALL) is the most common childhood malignancy and accounts for about 20% of cases of acute leukemia in adults. Chemotherapy has remained the backbone of first-line…
Report
March 22, 2022
Hodgkin’s Lymphoma – Epidemiology – Epidemiology – Hodgkin’s Lymphoma – Mature Markets
Clarivate Epidemiology’s coverage of Hodgkin’s lymphoma (HL) comprises epidemiological estimates of key patient populations in the major mature pharmaceutical markets (the United States, France…
Report
February 17, 2022
Polycythemia Vera – Current Treatment – Treatment Algorithms: Claims Data Analysis – Polycythemia Vera (US)
MARKET OUTLOOKPolycythemia vera (PV) is a rare hematological malignancy estimated to affect 50,000 people in the United States. Patients can be classified as having low- or high-risk PV, each of…
